KRBP

Kiromic BioPharma, Inc.

1.51 USD
-1.00 (-39.84%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Kiromic BioPharma, Inc. stock is down -52.81% since 30 days ago. The next earnings date is Aug 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 3 June’s closed higher than May.

About Kiromic BioPharma, Inc.

Kiromic BioPharma focuses on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate targeting Isomesothelin. It has license agreements with Mercer University; CGA 369 Intellectual Holdings, Inc.; and Longwood University.